Cytotoxicity of methotrexate and trimetrexate and its reversal by folinic acid in human leukemic CCRF-CEM cells with carrier-mediated and receptor-mediated folate uptake
- 31 December 1989
- journal article
- Published by Elsevier in Leukemia Research
- Vol. 13 (11), 981-987
- https://doi.org/10.1016/0145-2126(89)90005-2
Abstract
No abstract availableKeywords
This publication has 6 references indexed in Scilit:
- Mediated uptake of folate by a high-affinity binding protein in sublines of L1210 cells adapted to nanomolar concentrations of folateThe Journal of Membrane Biology, 1988
- High dose methotrexate therapy: Insecure rationale?Biochemical Pharmacology, 1988
- Identification of high affinity folate binding proteins in human erythrocyte membranes.Journal of Clinical Investigation, 1987
- Folate requirements of methotrexate-resistant human acute lymphoblastic leukemia cell linesBlood, 1986
- Uptake and efficacy of trimetrexate (TMQ, 2,4-diamino-5-methyl-6-[(3,4,5-trimethoxyanilino)methyl] quinazoline), a non-classical antifolate in methotrexate-resistant leukemia cells in vitroBiochemical Pharmacology, 1984
- Correlates of folate analog transport, pharmacokinetics and selective antitumor actionPharmacology & Therapeutics, 1980